Pyridostigmine is an acetylcholinesterase inhibitor used in the treatment of myasthenia gravis and certain cases of neuromuscular blockade. It works by inhibiting acetylcholinesterase, increasing acetylcholine availability at neuromuscular junctions. Pyridostigmine API is produced under GMP standards and is suitable for oral, tablet, and injectable formulations.

Pyridostigmine API is manufactured and supplied by ASTANDARDS | Artis Biotech, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.